Axogen, Inc. to Report First Quarter 2026 Financial Results

The medical device company will release earnings on April 28, 2026.

Apr. 14, 2026 at 11:05am

Got story updates? Submit your updates here. ›

A photorealistic studio still-life photograph featuring a polished metal medical device component, such as a nerve connector or nerve protector, arranged elegantly on a clean, monochromatic background with dramatic lighting and shadows, conceptually representing the precision and innovation of Axogen's medical technology.Axogen's innovative medical devices, designed to restore peripheral nerve function, are the focus of the company's upcoming quarterly earnings report.Alachua Today

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, announced that it will release its financial results for the first quarter of 2026 on Tuesday, April 28, 2026. The company will host an investment-community conference call and webcast at 8:00 a.m. ET following the release.

Why it matters

Axogen is a major player in the peripheral nerve repair market, and its quarterly earnings reports provide insight into the company's performance and the overall state of the industry. The upcoming report will be closely watched by investors and analysts to gauge Axogen's growth and profitability.

The details

Axogen will report its Q1 2026 financial results on April 28, 2026. The company will host a conference call and webcast at 8:00 a.m. ET to discuss the results. Investors can participate in the call by dialing toll-free at (877) 407-0993 or using the direct dial-in number at (201) 689-8795.

  • Axogen will release its Q1 2026 financial results on Tuesday, April 28, 2026.
  • The company will host a conference call and webcast at 8:00 a.m. ET on April 28, 2026.

The players

Axogen, Inc.

A global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Axogen's Q1 2026 earnings report to assess the company's performance and the overall state of the peripheral nerve repair market.

The takeaway

Axogen's upcoming earnings report will provide valuable insights into the company's growth and the broader trends in the peripheral nerve repair industry, which is a critical area of medical technology.